Standout Papers

CSF-1R inhibition alters macrophage polarization and blocks glioma progre... 2009 2026 2014 2020 1.8k
  1. CSF-1R inhibition alters macrophage polarization and blocks glioma progression (2013)
    Stephanie M. Pyonteck, Leila Akkari et al. Nature Medicine
  2. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype (2012)
    Şevin Turcan, Daniel Rohle et al. Nature
  3. PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells (2009)
    Anne-Marie Bleau, Dolores Hambardzumyan et al. Cell stem cell
  4. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma (2010)
    Jason T. Huse, Eric C. Holland Nature reviews. Cancer
  5. The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas (2016)
    Daniela F. Quail, Robert L. Bowman et al. Science
  6. Osteopontin-CD44 Signaling in the Glioma Perivascular Niche Enhances Cancer Stem Cell Phenotypes and Promotes Aggressive Tumor Growth (2014)
    Alexander Pietras, Amanda Katz et al. Cell stem cell
  7. Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy (2017)
    Tiffany R. Hodges, Martina Ott et al. Neuro-Oncology
  8. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis (2020)
    Guoqiang Chang, Lei Shi et al. Cancer Cell

Immediate Impact

16 by Nobel laureates 16 from Science/Nature 102 standout
Sub-graph 1 of 22

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
3 intermediate papers

Works of Jason T. Huse being referenced

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas:Guideline from the College of American Pathologists in Collaboration with the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology
2022
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
2014
and 2 more

Author Peers

Author Last Decade Papers Cites
Jason T. Huse 4665 6040 3569 129 12.0k
Howard Colman 5868 5534 3671 149 11.3k
Karl H. Plate 2579 10748 5926 155 16.9k
Georg Breier 1585 11960 5115 114 17.4k
Qiulian Wu 4050 7228 4153 65 12.8k
Richard J. Gilbertson 7279 10203 3361 150 16.4k
Anita B. Hjelmeland 4503 8000 5144 97 14.3k
Kristin Waite 3867 3771 1589 102 9.4k
Gaetano Finocchiaro 3179 3865 1612 213 8.1k
Frank B. Furnari 2995 7799 2988 124 11.9k
Gregory J. Riggins 4754 11602 5201 117 18.1k

All Works

Loading papers...

Rankless by CCL
2026